These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 25423557)
1. Validation of a nomogram for predicting the probability of carcinoma in patients with intraductal papillary mucinous neoplasm in 180 pancreatic resection patients at 3 high-volume centers. Shimizu Y; Yamaue H; Maguchi H; Yamao K; Hirono S; Osanai M; Hijioka S; Kanemitsu Y; Sano T; Senda Y; Bhatia V; Yanagisawa A Pancreas; 2015 Apr; 44(3):459-64. PubMed ID: 25423557 [TBL] [Abstract][Full Text] [Related]
2. Pre-operative nomogram predicting malignant potential in the patients with intraductal papillary mucinous neoplasm of the pancreas: focused on imaging features based on revised international guideline. Hwang JA; Choi SY; Lee JE; Kim SS; Lee S; Moon JY; Heo NH Eur Radiol; 2020 Jul; 30(7):3711-3722. PubMed ID: 32095876 [TBL] [Abstract][Full Text] [Related]
3. Validation of a nomogram to predict the risk of cancer in patients with intraductal papillary mucinous neoplasm and main duct dilatation of 10 mm or less. Jung W; Park T; Kim Y; Park H; Han Y; He J; Wolfgang CL; Blair A; Rashid MF; Kluger MD; Su GH; Chabot JA; Yang CY; Lou W; Valente R; Del Chiaro M; Shyr YM; Wang SE; van Huijgevoort NCM; Besselink MG; Yang Y; Kim H; Kwon W; Kim SW; Jang JY Br J Surg; 2019 Dec; 106(13):1829-1836. PubMed ID: 31441048 [TBL] [Abstract][Full Text] [Related]
4. Differential diagnosis of benign or malignant intraductal papillary mucinous neoplasm of the pancreas by multidetector row helical computed tomography: evaluation of predictive factors by logistic regression analysis. Takeshita K; Kutomi K; Takada K; Haruyama T; Fukushima J; Aida R; Takada T; Furui S J Comput Assist Tomogr; 2008; 32(2):191-7. PubMed ID: 18379300 [TBL] [Abstract][Full Text] [Related]
5. Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases. Nara S; Onaya H; Hiraoka N; Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T Pancreas; 2009 Jan; 38(1):8-16. PubMed ID: 18665010 [TBL] [Abstract][Full Text] [Related]
6. The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas. Hirono S; Tani M; Kawai M; Okada K; Miyazawa M; Shimizu A; Kitahata Y; Yamaue H Ann Surg; 2012 Mar; 255(3):517-22. PubMed ID: 22301608 [TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium. Attiyeh MA; Fernández-Del Castillo C; Al Efishat M; Eaton AA; Gönen M; Batts R; Pergolini I; Rezaee N; Lillemoe KD; Ferrone CR; Mino-Kenudson M; Weiss MJ; Cameron JL; Hruban RH; D'Angelica MI; DeMatteo RP; Kingham TP; Jarnagin WR; Wolfgang CL; Allen PJ Ann Surg; 2018 Jan; 267(1):157-163. PubMed ID: 28079542 [TBL] [Abstract][Full Text] [Related]
8. Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast-enhanced endoscopic ultrasonography. Harima H; Kaino S; Shinoda S; Kawano M; Suenaga S; Sakaida I World J Gastroenterol; 2015 May; 21(20):6252-60. PubMed ID: 26034360 [TBL] [Abstract][Full Text] [Related]
9. Can long-term follow-up strategies be determined using a nomogram-based prediction model of malignancy among intraductal papillary mucinous neoplasms of the pancreas? Hijioka S; Shimizu Y; Mizuno N; Hara K; Imaoka H; Mekky MA; Bhatia V; Nagashio Y; Hasegawa T; Shinagawa A; Sekine M; Tajika M; Tanaka T; Ishihara M; Niwa Y; Yamao K Pancreas; 2014 Apr; 43(3):367-72. PubMed ID: 24622065 [TBL] [Abstract][Full Text] [Related]
10. External validation of nomogram for predicting malignant intraductal papillary mucinous neoplasm (IPMN): from the theory to the clinical practice using the decision curve analysis model. Casadei R; Ricci C; Ingaldi C; Cornacchia A; Migliori M; Di Marco M; Pagano N; Serra C; Alberici L; Minni F Updates Surg; 2021 Apr; 73(2):429-438. PubMed ID: 33620642 [TBL] [Abstract][Full Text] [Related]
11. Should all branch-duct intraductal papillary mucinous neoplasms be resected? Plichta JK; Ban K; Fridirici Z; Godambe AS; Yong S; Pappas S; Abood GJ; Aranha GV Am J Surg; 2015 Mar; 209(3):478-82. PubMed ID: 25605032 [TBL] [Abstract][Full Text] [Related]
12. Pancreatic juice cytology in IPMN of the pancreas. Yamaguchi K; Nakamura M; Shirahane K; Kawamoto M; Konomi H; Ohta M; Tanaka M Pancreatology; 2005; 5(4-5):416-21; discussion 421. PubMed ID: 15985766 [TBL] [Abstract][Full Text] [Related]
13. Pancreatic juice cytology in the diagnosis of intraductal papillary mucinous neoplasm of the pancreas: significance of sampling by peroral pancreatoscopy. Yamaguchi T; Shirai Y; Ishihara T; Sudo K; Nakagawa A; Ito H; Miyazaki M; Nomura F; Saisho H Cancer; 2005 Dec; 104(12):2830-6. PubMed ID: 16287152 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological Meaning of Size of Main-Duct Dilatation in Intraductal Papillary Mucinous Neoplasm of Pancreas: Proposal of a Simplified Morphological Classification Based on the Investigation on the Size of Main Pancreatic Duct. Kang MJ; Jang JY; Lee S; Park T; Lee SY; Kim SW World J Surg; 2015 Aug; 39(8):2006-13. PubMed ID: 25894399 [TBL] [Abstract][Full Text] [Related]
15. A nomogram for predicting the probability of carcinoma in patients with intraductal papillary-mucinous neoplasm. Shimizu Y; Kanemitsu Y; Sano T; Senda Y; Mizuno N; Yamao K World J Surg; 2010 Dec; 34(12):2932-8. PubMed ID: 20845037 [TBL] [Abstract][Full Text] [Related]
16. Predicting malignant intraductal papillary mucinous neoplasm: a single-center review. Cone MM; Rea JD; Diggs BS; Douthit MA; Billingsley KG; Sheppard BC Am J Surg; 2011 May; 201(5):575-9. PubMed ID: 21545902 [TBL] [Abstract][Full Text] [Related]
17. Proposed Nomogram Predicting the Individual Risk of Malignancy in the Patients With Branch Duct Type Intraductal Papillary Mucinous Neoplasms of the Pancreas. Jang JY; Park T; Lee S; Kim Y; Lee SY; Kim SW; Kim SC; Song KB; Yamamoto M; Hatori T; Hirono S; Satoi S; Fujii T; Hirano S; Hashimoto Y; Shimizu Y; Choi DW; Choi SH; Heo JS; Motoi F; Matsumoto I; Lee WJ; Kang CM; Han HS; Yoon YS; Sho M; Nagano H; Honda G; Kim SG; Yu HC; Chung JC; Nagakawa Y; Seo HI; Yamaue H Ann Surg; 2017 Dec; 266(6):1062-1068. PubMed ID: 27607098 [TBL] [Abstract][Full Text] [Related]
18. New Model for Predicting Malignancy in Patients With Intraductal Papillary Mucinous Neoplasm. Shimizu Y; Hijioka S; Hirono S; Kin T; Ohtsuka T; Kanno A; Koshita S; Hanada K; Kitano M; Inoue H; Itoi T; Ueki T; Matsuo K; Yanagisawa A; Yamaue H; Sugiyama M; Okazaki K Ann Surg; 2020 Jul; 272(1):155-162. PubMed ID: 30499803 [TBL] [Abstract][Full Text] [Related]
19. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification. Serikawa M; Sasaki T; Fujimoto Y; Kuwahara K; Chayama K J Clin Gastroenterol; 2006 Oct; 40(9):856-62. PubMed ID: 17016145 [TBL] [Abstract][Full Text] [Related]
20. Thirty years of experience with intraductal papillary mucinous neoplasm of the pancreas: from discovery to international consensus. Tanaka M Digestion; 2014; 90(4):265-72. PubMed ID: 25591885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]